5.2% CAGR to take Cervical Cancer Treatment Market to USD 10.6 bn by 2025
The latest market report published by Credence Research, Inc. “Global Cervical Cancer Treatment Market - Growth, Future Prospects, Competitive Analysis, 2018 - 2026,” the global cervical cancer treatment market is expected to expand at a CAGR of 5.2% from 2018 to 2026.Market Insights
According to the latest research citings of World Health Organization (WHO) in 2018, approximately 570,000 new cases if cervical cancer were reported which eventually represents 6.6% of all female cancers. The early manifestation of cervical cancer are vaginal bleeding after sexual intercourse with excruciating pain. The 2 main types of cervical cancer are squamous cell carcinoma and adenocarcinoma. Early diagnosis and vaccination with Gardasil can prevent the advent of cervical cancer. In the last decade there has been a paradigm shift in the treatment regimen from chemotherapy to targeted therapy. Biologics in the phase III clinical trials such as nimotuzumab and atezolizumab will provide a positive thrust to the cervical cancer treatment market growth.
Get Sample: https://www.credenceresearch.com/sample-request/59521
Browse the full report Cervical Cancer Treatment Market - Growth, Future Prospects, Competitive Analysis, 2018 – 2026 report at https://www.credenceresearch.com/report/cervical-cancer-treatment-market
Chemotherapy is reigning the product segment for cervical cancer treatment market. Placitaxel, cisplatin, carboplatin, gemcitabine are given either alone or in combination with radiation therapy for patients suffering with advanced stage cervical cancer. The combination therapy is helpful but causes severe adverse effects. Cervical hysterectomy is helpful in women suffering with early stage cervical cancer. Targeted drug therapy will be the fastest growing market on account of its excellent clinical outcomes, dose tolerability and patient compliance.
North America presently maintains supremacy in the regional segment for cervical cancer treatment market. According to Center for Disease Control And Prevention (CDC), cervical cancer is the second most common type of cancer in women after breast cancer resulting in mortality due to lack of early screening and medical intervention. Rising public health awareness and affordable reimbursement scenario drive the cervical cancer treatment market growth in North America. In Europe cervical cancer is responsible for the mortality of 70% patient actively diagnosed with cervical cancer. Presence of key players such as F.Hoffman La-Roche AG., Merck & Co., Inc., and GlaxoSmithkline, Plc. etc. propel the cervical cancer treatment market growth in the European Region. Asia Pacific will be the fastest growing market during the forecast period owing to the presence of huge generic market and proactive government policies to fight cervical cancer.
Biopharmaceutical companies having a strong foothold in the cervical cancer treatment market are, Allergan, Plc., Biocon Ltd., CooperSurgical, Inc., Eli Lilly & Company, F.Hoffman La-Roche AG, GlaxoSmithkline Plc., Ethicon, Inc., Merck & Co., Inc., Teva Pharmaceutical Industries Ltd. and Varian Medical Systems, Inc.
Key Market Movements:
Increasing cases of women being diagnosed for cervical cancer throughout the globe
Rising public health awareness and affordable reimbursement scenario for the generic drugs employed for the treatment of cervical cancer
Vaccination such as Gardasil is helpful in prevention of HPV infection and strong biologics pipeline with drugs in phase III clinical trials such as nimotuzumab and atezolizumab
Get Sample: https://www.credenceresearch.com/sample-request/59521
About Us
Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we've manufactured a firm extraordinarily prepared to this task.
Who we are
Credence Research is a worldwide firm, containing more than 15 research consultants and almost 100 research and information professionals.
Our customers mirror our worldwide nature. Around 45% are in Europe, 30% in the Americas, 13% in Asia Pacific and 12% in the Middle East and Africa.
Our firm is intended to work as one. We are a solitary global research organization united by a solid arrangement of qualities, concentrated on customer effect.
105 N 1st ST #429, SAN JOSE,
CA 95103, United States
sales@credenceresearch.com
+1-800-361-8290
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release 5.2% CAGR to take Cervical Cancer Treatment Market to USD 10.6 bn by 2025 here
News-ID: 1510581 • Views: …
More Releases from Acute Market Reports
Clad Pipe Market | Global Industry Size, Development Strategy, Revenue Analysis, …
The global market for clad pipe is projected to reach $3870.4 million by 2031, up from $2500 million in 2022, representing a CAGR of 5.10 percent over the period from 2023 to 2031. During the projected period of 2023 to 2031, it is anticipated that the market for clad pipes will exhibit a CAGR of 5.10%. A Clad Pipe is a form of steel pipe with a layer of corrosion-resistant…
Explosion Proof Equipment Market 2031 | Global Industry Size, Development Strate …
According to a new market research report published by Acute Market Reports, "Explosion Proof Equipment Market (by End-use Vertical (Oil & Gas, Industrial Manufacturing & Processing, Energy & Mining, Pharmaceuticals, and Other Verticals), by Applicable System Type (Material Handling Systems, Surveillance Systems, Power Supply Systems, Motors, Automation Systems, and Others), by Hazardous Zone (Zone 0, Zone 20, Zone 1, Zone 21, Zone 2, Zone 22), by Geography (North America, Europe,…
Acquired von Willebrand syndrome (AvWS) Treatment Market - Growth, Future Prospe …
Acquired von Willebrand syndrome is a highly heterogeneous bleeding disorder, usually displays mild to moderate hemorrhagic symptoms that may at times be severe too. Many a time the severity increases post-surgery. AvWS is considered as a rare disorder, however, the actual prevalence is not as rare. In case the laboratory findings diagnoses vWD in a patient with no family history, AvWS associated conditions is usually explored. The acquired von willebrand…
More Releases for Cervical
Cervical Cancer Vaccines Market – Insights
Combining the analysis capabilities and data integration with the relevant findings, the report has predicted the strong future growth of the Cervical Cancer Vaccines Market in all its geographical and product segments. The Cervical Cancer Vaccines market research gathers data about the customers, marketing strategy, competitors. The Cervical Cancer Vaccines The manufacturing industry is becoming increasingly dynamic and innovative, with more number of private players enrolling the industry.
Free Download PDF…
Cervical Pillows Market Report 2018: Segmentation by Product (Cradle Pillows, Ne …
Global Cervical Pillows market research report provides company profile for Innocor, Lohmann & Rauscher International, PharMeDoc, Crown Medical Products, CNH Pillow, Therapeutic Pillow International, Djo Global, Alex Orthopedic, Mediflow, Coop Home Goods, Core Products International and Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth…
Rising Incidence of Cervical Cancer Dialing Growth for Cervical Cancer Diagnosti …
According to the research study, in 2013, the global market for cervical cancer diagnostic tests was valued at US$5.9 bn and is estimated to reach a value of US$8.9 bn by the end of 2020. The market is anticipated to exhibit a healthy 6.10% CAGR between 2014 and 2020.
Report Overview @ https://www.transparencymarketresearch.com/cervical-cancer-diagnostic-tests-market.html
Cervical cancer is a type of cancer that develops in the cervix of women. This type of cancer does…
Cervical Cancer Diagnostic Tests Market
A new market research report has been recently published by Transparency Market Research, a global market intelligence firm, and made available on the company website. The research study talks about the current scenario of global cervical cancer diagnosis tests market, along with the growth prospects of the market. The research study, titled “Cervical Cancer Diagnostic Tests Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020,”…
India Cervical Cancer Screening Market India Cervical Cancer Sales Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
Overview of the Cervical Cancer
1.1 Introduction
1.2 Stages of the Cervical Cancer
1.2.1 Stage 0
1.2.2 Stage 1
1.2.3 Stage 2
1.2.4 Stage 3
1.2.5 Stage 4
Occurrence Rate of the Cervical Cancer
2.1 Incidence of the Cervical Cancer in Indian States
…
Global Cervical Cancer Diagnostic Testing Devices Market 2017, Global Cervical C …
Focuses on top manufacturers in global market, with Production, price, revenue and market share for each manufacturer
Global Bronchoscopic Devices Market 2017, presents a professional and in-depth study on the current state of the Bronchoscopic Devices market globally, providing basic overview of Bronchoscopic Devices market including definitions, classifications, applications and industry chain structure, Bronchoscopic Devices Market report provides development policies and plans are discussed as well as manufacturing processes and cost…